Victor Aboyans
Prof Victor Aboyans is an expert in Cardiology at Centre Hospitalier Universitaire de Limoges (France). As of October 2026, ScienceLeadR ranks Victor Aboyans in the top 1% of experts worldwide for Peripheral Vascular Diseases, Arterial Occlusive Diseases and Arteriosclerosis. Victor Aboyans has authored 740 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 2,857 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Endocrinology - Biostatistics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 740
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Low-grade inflammation and cardiovascular events among patients with chronic kidney disease. PMID 42906920 — kidney diseases, heart failure, c-reactive protein, cardiovascular diseases, cohort studies, kidney, therapeutics, history, renal replacement therapy | Eur J Prev Cardiol | 2026 | 0 |
| Smoke, spirits, and opioids-the cardiovascular toll of substance use. PMID 42872546 — cardiovascular diseases, smoke | Eur J Prev Cardiol | 2026 | 0 |
| Coronary Imaging and Cardiovascular Risk: Is Anatomy Enough? PMID 42830575 — cardiovascular diseases, anatomy | Eur J Prev Cardiol | 2026 | 0 |
| The changing face of obesity in cardiovascular prevention. PMID 42766582 — cardiovascular diseases, obesity | Eur J Prev Cardiol | 2026 | 0 |
| Beyond one-size-fits-all: sex-specific approaches to cardiovascular prevention. PMID 42767661 — cardiovascular diseases, sex | Eur J Prev Cardiol | 2026 | 0 |
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 9
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Addiction in Intensive Cardiac Care Units NCT05063097 — dronabinol, antidepressive agents, research design, buprenorphine, heart diseases, n-methyl-3,4-methylenedioxyamphetamine, heroin, hospitalization, cocaine, methadone, pharmaceutical preparations, benzodiazepines, heart, substance-related disorders, psychotropic drugs, prevalence, tobacco use, intensive care units, barbiturates, amphetamines, smoking, cannabinoids, antidepressive agents, tricyclic, illicit drugs | N/A | Active not recruiting | 2021 |
LeadR Networks
Main global connection map